T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Intel
INTC
$509B
| $299M | 0.03% |
14,927,928
-66,320
| -0.4% | -$1.49M |
|
352
Zoetis
ZTS
$30.4B
| $299M | 0.03% |
1,836,353
-2,289,668
| -55% | -$409M |
|
353
Nike
NKE
$60.1B
| $297M | 0.03% |
3,919,997
-552,139
| -12% | -$43.4M |
|
354
Biogen
BIIB
$30.9B
| $296M | 0.03% |
1,933,716
+21,170
| +1% | +$3.57M |
|
355
iShares Russell 1000 Growth ETF
IWF
$128B
| $294M | 0.03% |
2,927,568
-171,608
| -6% | -$16.9M |
|
356
VF Corp
VFC
$5.73B
| $294M | 0.03% |
13,682,830
+1,491,972
| +12% | +$30.4M |
|
357
Novanta
NOVT
$6.32B
| $291M | 0.03% |
1,907,841
-157,292
| -8% | -$26.6M |
|
|
SOBO
358
South Bow Corp
SOBO
$7.64B
| $291M | 0.03% |
+12,337,055
| New | +$302M |
|
359
Rambus
RMBS
$11B
| $288M | 0.03% |
5,449,128
+4,445,146
| +443% | +$227M |
|
360
Vistra
VST
$49.2B
| $286M | 0.03% |
2,072,045
+132,530
| +7% | +$18.4M |
|
361
SS&C Technologies
SSNC
$18.8B
| $282M | 0.03% |
3,721,367
-59,807
| -2% | -$4.47M |
|
362
CBRE Group
CBRE
$42.7B
| $282M | 0.03% |
2,147,783
+991,354
| +86% | +$130M |
|
363
Ares Management
ARES
$32.1B
| $281M | 0.03% |
1,588,173
-131,255
| -8% | -$22.4M |
|
364
Oneok
OKE
$58.3B
| $280M | 0.03% |
2,790,760
+1,971,147
| +240% | +$202M |
|
365
Vulcan Materials
VMC
$36.3B
| $279M | 0.03% |
1,083,129
-32,884
| -3% | -$8.84M |
|
366
Crinetics Pharmaceuticals
CRNX
$8.96B
| $277M | 0.03% |
5,414,505
+469,748
| +9% | +$26.3M |
|
367
Kymera Therapeutics
KYMR
$9.48B
| $276M | 0.03% |
6,870,333
+224,859
| +3% | +$10.2M |
|
|
SUM
368
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $271M | 0.03% |
5,353,933
-3,855,566
| -42% | -$180M |
|
369
CubeSmart
CUBE
$9.28B
| $270M | 0.03% |
6,291,797
-522,592
| -8% | -$25.1M |
|
370
Magna International
MGA
$18.6B
| $263M | 0.03% |
6,296,341
-183,169
| -3% | -$7.87M |
|
371
DuPont de Nemours
DD
$19.5B
| $260M | 0.03% |
2,719,376
+267,680
| +11% | +$27.8M |
|
372
Cognizant
CTSH
$26.2B
| $260M | 0.03% |
3,380,880
-620,818
| -16% | -$48.6M |
|
373
Procore
PCOR
$8.81B
| $260M | 0.03% |
3,468,417
-1,648,913
| -32% | -$117M |
|
374
Dollar Tree
DLTR
$24.7B
| $258M | 0.03% |
3,447,610
-1,724,953
| -33% | -$118M |
|
375
Middleby
MIDD
$5.38B
| $257M | 0.03% |
1,895,553
+35,449
| +2% | +$4.89M |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.